BMYBRISTOL MYERS SQUIBB COSEC EDGAR
Use with Claude or ChatGPT

BRISTOL MYERS SQUIBB CO (BMY) Overview

Healthcare • NYSE • CIK 0000014272

Loading...

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Market Cap
$127.43B
P/E (TTM)
13.8x
Rev Growth (TTM)
+4.2%
Net Margin (TTM)
18.5%
FCF Yield (TTM)
7.3%
FCF Margin (TTM)
18.6%
Figures as of September 30, 2026
Data coverage notes

Operating income: no tagged operating-income figure (OperatingIncomeLoss) resolved for the trailing twelve months, so MetricDuck computes revenue minus total costs and expenses, and here that equals the filer's income before taxes (within 1%), so it may already be after interest and other non-operating items; if so, it is not EBIT. Operating margin, interest coverage, ROIC and EV/EBIT are built on it; no EBIT is synthesised.

Filings

Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.

10-Q2026 Q32026-10-29source
8-KEarnings2026-10-29source
10-Q2026 Q22026-07-30source
8-KEarnings2026-07-30source
8-KMay 20262026-05-08source
What your agent reads

Investor Relations

investor.bms.com

Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.

Company-published, not SEC-audited

Earnings

Q3
18 days ago
8-K release
Revenue
$13.07B
+6.9%
Net Income
$2.16B
-1.8%
EPS
$1.05
-2.8%
Earnings call2026 Q1· machine-transcribedtranscript
Most recent quarterly earnings snapshot

Cash Flow Health

Free Cash Flow8/8 positive
TTM$9.3B
Q3 '26
$3.8B+24%
Q2 '26
$3.1B+308%
FCF Margin
TTM18.6%
Q3 '2629.4%+23%
Sector: 3.0%Top 25%
OCF Margin
21.3%
OCF/NI1.15x
CapEx Coverage
7.8x
FCF Yield7.3%
FCF Growth (3Y)-7%
Cash Conversion Cycle
33 days
DSO: 66+DIO: 65−DPO: 97
Factsheet →
Cash flow trends & capital efficiency

Capital Allocation

Total Shareholder Yield
TTM4.0%
Div Yield4.0%
Dividend & Payout Metrics
Dividend Yield (TTM)4.0%
FCF Payout Ratio55.3%
Free Cash Flow (TTM)$9.3B
Stock Repurchases ()$0
Capital Return / FCF55.1%
Shares Outstanding (YoY)0.4%
Est. Dividends Paid (TTM)$5.1B
Shows how management rewards shareholders

Valuation Metrics

Price-to-EarningsTTM
13.8x
Volatile
8Q: 13.7x-22597%
Valuation Lenses
Earnings
13.8x
vs – sector
Cash Flow
17.0x
EV/FCF vs –
Growth-Adj
0.3xPEG
Undervalued for growth
Quality-Adj
1.0P/E per %ROIC
ROIC: 14.2%
Shareholder Returns
Dividend
4.0%
Buyback
–
Total Yield
4.0%
Market Cap$127.43B
EV$157.72B

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Multi-angle valuation analysis with sector context

Margins & Efficiency

ROIC 75th pctile
Profitability Cascade
Gross
69.2%
Operating
22.6%
Top 25% in sector
Net
18.5%
Margins Unknown
Return on Invested CapitalTTM
14.2%
Moderate
+0.1% YoY8Q: 13.1%+11.3%
P25MedianP75
75th pctl (med: -7.7%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
18.5%
8Q: 17.3%
Asset Turnover
0.56x
8Q: 0.53x
Leverage (1+D/E)
2.83x
D/E: 1.83x
DuPont: 29.3% ≈ 14.2% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
6.53x
8Q:6.68x
-20.1%
Invested Cap Turn
0.87x
8Q:0.84x
+10.2%
CapEx Intensity
2.4%
8Q:2.4%
CapEx/Depreciation
0.49x
FCF vs Net Margin Gap+0.1 pts
Depreciation Rate Trend
⚠ Declining -35.9%
Margin trends, ROIC, and capital efficiency

Balance Sheet & Solvency

ND/EBITDA 2.4x
Net Debt / EBITDA
2.4xNet Debt: $30.30B
Interest Coverage
6.9x
+Strong interest coverage: 6.9x
Leverage Metrics
Debt-to-Equity
1.83x
Balance sheet risk & solvency analysis

Related Research

1 related post